Clinical Trial Update: A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision [Phase 1, Phase 2]

View source ↗

Summary

AIV001 was studied in Phase 1/2 trials for safety and efficacy in wound healing after a surgical incision; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scar
• Wound Healing

Drugs mentioned

• AIV001

Snippet

Sponsor: AiViva BioPharma, Inc. | Conditions: Scar, Incision | Phase 1, Phase 2 | Status: COMPLETED